“Uncertain international circumstances and enlightened self-interest help prevent greater losses.”
Lunit Study in Radiology Highlights Trust Gap Between Radiologists and AI in Breast Cancer Screening
U.S. FDA grants interchangeable designation to YUFLYMA, Celltrion's biosimilar to Humira
K-Beauty Trouble-Care Leader 'Fation' Debuts Nosca9 Deep Pore Cleanser in the U.S
GC Biopharma Receives MFDS Approval for World's First Recombinant Anthrax Vaccine
Ustekinumab Biosimilars May Ease Budget Pressures and Improve Access in Europe, IMKASID 2025 Analysis Shows
ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK
PanGen contracts with Huonslab for biopharmaceutical process characterization study
Medytox signs botulinum toxin distribution agreement worth USD 73 million with Blau Farmacêutica, from Brazil
Celltrion's STEQEYMA (ustekinumab-stba), now added to the Costco Member Prescription Program
Handok’s Collaborator, Compass Therapeutics, Announces Positive Topline Results from Phase 2/3 of Tovecimig (HDB001A)
ST PHARM Participates in DCAT Week 2025, Seeking Global Partnerships
Bioneer Participates in the American Academy of Dermatology (AAD)
SK bioscience and IVI Announce the 2025 Recipients of the ‘Park MahnHoon Award’ Four Honorees Recognized
Medytox signs botulinum toxin distribution agreement worth USD 73 million with Blau Farmacêutica, from Brazil
Samsung Biologics recognized for leadership band in water security
HK inno.N’s K-CAB wins a landmark victory in the second-instance trial for its substance patent
Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States
Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy
Samsung Biologics signs manufacturing deal with European pharmaceutical company
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
ST Pharm Banwol Campus Awarded EcoVadis 'Gold' Medal
HK inno.N-IMBiologics-Y-Biologics Transfer Autoimmune Disease Drug Tech to China
SK bioscience and CEPI Deepen Partnership for Pandemic Prevention, Preparedness and Response
ST Pharm, honored with two awards at the 'Korea Biopharma Excellence Awards 2024'
'LECLAZA' in combination with RYBREVANT Receives First U.S. FDA Approval for a Korea-Born Anticancer Drug
Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study
Daewoong Pharmaceutical's 'Fexuprazan' Expands into Latin America: Enters $300 Million Market in Mexico, Chile, and Ecuador
Samsung Biologics joins the Pharmaceutical Supply Chain Initiative as Supplier Partner
Boryung Hosts 2024 Humans In Space Roadshow in Las Vegas
